HAEMONETICS CORP

Haemonetics Corporation is a medical technology provider that supplies devices, software, and consumables to the healthcare sector. The company manages three primary segments: Plasma, Blood Center, and Hospital. Its Plasma division offers automated collection equipment and donor management software for source plasma facilities. The Blood Center unit provides automated apheresis systems to collect and process platelets, plasma, and red cells. Its Hospital segment delivers vascular closure devices, sensor-guided guidewires, esophageal protection tools, diagnostic hemostasis analyzers, surgical cell salvage systems, and transfusion management software. Customers comprise biopharmaceutical companies, blood collection centers, hospitals, group purchasing organizations, and health agencies.

The company sells products in approximately 90 countries via a direct sales force and third-party distributors across about 87 countries. Consumable manufacturing occurs mainly in North America and Malaysia, with contract partners producing components in Japan, Singapore, Thailand, Indonesia, and the Philippines. Equipment production takes place in Malaysia, Australia, and the United States. The text does not identify the company's corporate headquarters.

Summary of the business section of Haemonetics's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.